Back to top

News

  /  Updates   /  News

The main objective of the International Diploma in Molecular Biology Applied to Clinical Oncology is to provide an excellence international educational program with high academic and professional European experts in the different oncological areas for the diagnosis and treatment of cancer-based on molecular biology.  Each year, the program provides an invaluable opportunity to participate in the program. Each Fellowship is a stimulating challenge for talented young oncologists or in related areas who seek leading careers in oncology areas in public institutions. Download the Complete Program Diploma here Visit the webpage

  O LACOG e o Instituto Ética promoverão pelo nono ano consecutivo o Best of ASCO 2022 - Edição Brasil, único evento no país oficialmente licenciado pela American Society of Clinical Oncology (ASCO), que acontecerá nos dias 10 e 11 de junho de 2022 em formato híbrido. Neste evento, um painel de especialistas seleciona os abstracts mais relevantes com impacto na prática clínica apresentados no ASCO Annual Meeting 2022, a mais importante conferência de oncologia do mundo.   Inscreva-se e participe!

O Instituto Vencer o Câncer lançou o projeto Amor à Pesquisa Contra o Câncer no Brasil, que tem como objetivo estruturar novos centros de pesquisa no país e aumentar o acesso dos brasileiros a protocolos de estudos em tratamentos inovadores.Nesta primeira etapa, as instituições selecionadas pelo edital estão localizadas em Manaus (AM), Belém (PA), São Luís (MA), João Pessoa (PB), Campo Grande (MS) e Feira de Santana (BA).O projeto representa um esforço conjunto de associações de saúde, indústria e pesquisadores visionários para impulsionar estudos clínicos em Oncologia no Brasil.A iniciativa do IVOC conta com a consultoria técnica do LACOG, patrocínio da Associação da Indústria Farmacêutica de Pesquisa (Interfarma), Sindicato da Indústria de Produtos Farmacêuticos (Sindusfarma) e Eurofarma. Saiba mais sobre o projeto

Essa é a primeira edição do evento educacional LATAM CANCER CONNECTION, uma iniciativa do LACOG e da MSD. Oncologistas renomados em câncer de mama, ginecológico e genitourinário apresentarão as principais atualizações das áreas no cenário mundial. O objetivo dos encontros é levar o conhecimento técnico para a prática clínica na América Latina. O evento acontecerá nos dias 29 a 31 de março, a partir das 19 horas. A programação será online e gratuita, e terá tradução para o português e espanhol. Acesse o site e saiba mais

  A Conferência Brasileira de Câncer de Mama - Best of SABCS Brazil é um evento organizado pelo Latin American Cooperative Oncology Group (LACOG) e pelo Grupo Brasileiro de Estudos em Câncer de Mama (GBECAM), instituições brasileiras dedicadas à educação e pesquisa em Câncer de Mama. A conferência tem como objetivo trazer atualizações do tratamento de doença inicial e metastática, apresentando as novas perspectivas e aplicabilidade dos testes moleculares e genéticos em câncer de mama, além dos principais avanços em cirurgia, radioterapia, tratamentos sistêmicos e o impacto na prática clínica. O Best of SABCS Brazil é um evento oficialmente licenciado do San Antonio Breast Cancer Symposium, um dos mais relevantes congressos mundiais que debate pesquisa básica, translacional e clínica em câncer de mama. Neste evento são apresentados os principais abstracts do SABCS na íntegra, e discutidos seus resultados e impacto na prática clínica.   Inscreva-se gratuitamente

Although the COVID-19 pandemic has still prevented on-site attendance at this year’s WCLC (September 8th - September 14th) and ESMO meeting (September 16th – September 21st), the global oncology community presented a large range of relevant and potentially practice-changing findings. This report summarizes important findings relating to the management of patients with lung cancer, starting with the expansion of treatments and insights in the early-stage disease setting. A multitude of studies investigating drugs targeting EGFR and HER2 are presented as well as checkpoint inhibition that is being implemented in other entities apart from NSCLC such as small-cell lung cancer and mesothelioma. Last but not least, this special issue includes a section about anti-cancer vaccination after failure of immune checkpoint inhibition and a first-in-class selective immunomodulating microtubule-binding agent that has the potential of a preferred second/third-line treatment option in the setting of NSCLC with EGFR wildtype. Download the full report

July 14-15, 2022 | Online and On-Demand The Lancet Summit: Cancer care in Asia and Latin America will bring together key opinion leaders from across Asia and Latin America to highlight clinical and global oncology topics relevant for both regions in a post-pandemic world.  The programme will encourage delegates to share experiences and learnings in both settings, foster interdisciplinary and multinational collaboration, and help inspire ideas to restore and improve cancer care and control. Topics include: Impact of COVID-19 on cancer care - future challenges and prioritiesHealth systems resiliencePalliative careCancer politics and policyNew technologies in cancer care Submissions are invited for contributed talks by February 18, 2022. To view the speakers and register visit: http://thelancetsummit.com/aosl

  The Innovation in Breast Cancer Symposium, will be held in online format on February 17th and 18th, 2022. The two-day international scientific program aims to provide state-of-the-art information on breast cancer, achieving a balance of clinical, translational, and basic research, as well as providing a forum for interaction, communication, and interdisciplinary education for specialists with a special interest in breast cancer.     The registration period is now open. You can find all the information on the website through which you will have access to the registration section, general information, etc. Learn more: www.innovationinbreastcancer.com

  It is with great satisfaction that we invite you all to participate in the conference SNOLA 2022 – Translational research to current and future treatments, which will take place on February 11th and 12th, 2022, 100% online. This will be the largest and most complete Neuro Oncology event in Latin America. Snola was born and remains focused on making accessible the content of knowledge and integration of all areas involved in oncological treatments of the of the Central Nervous System, therefore, we are committed to delivering the best of the best to Latin American specialists, as we always seek to do. Our last biannual congress had more than 1000 participants, 201 brazilian speakers, 76 international speakears and 7 sponsor. This success was achieved despite all the difficulties that this multidisciplinary area faces in scientific and practical terms. The world pandemic scenario made us change our plans, and the conference that would take place in 2020 in Buenos Aires had to be postponed. In view of the new reality, we proposed to hold the congress 100% online with scientific programming focused on what is new in our field, themes and studies that have shownpromise for new protocols, new approaches to the already known ones, as well